9-114403966-A-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015404.4(WHRN):c.2348T>A(p.Val783Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V783A) has been classified as Benign.
Frequency
Consequence
NM_015404.4 missense
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2DInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
- autosomal recessive nonsyndromic hearing loss 31Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: MODERATE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Usher syndrome type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015404.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| WHRN | NM_015404.4 | MANE Select | c.2348T>A | p.Val783Glu | missense | Exon 10 of 12 | NP_056219.3 | ||
| WHRN | NM_001173425.2 | c.2345T>A | p.Val782Glu | missense | Exon 10 of 12 | NP_001166896.1 | |||
| WHRN | NM_001346890.1 | c.1295T>A | p.Val432Glu | missense | Exon 6 of 8 | NP_001333819.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| WHRN | ENST00000362057.4 | TSL:1 MANE Select | c.2348T>A | p.Val783Glu | missense | Exon 10 of 12 | ENSP00000354623.3 | ||
| WHRN | ENST00000265134.10 | TSL:1 | c.1199T>A | p.Val400Glu | missense | Exon 10 of 12 | ENSP00000265134.6 | ||
| WHRN | ENST00000674036.9 | c.2138T>A | p.Val713Glu | missense | Exon 9 of 11 | ENSP00000501297.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 6.85e-7 AC: 1AN: 1459064Hom.: 0 Cov.: 74 AF XY: 0.00 AC XY: 0AN XY: 725890 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces valine with glutamic acid at codon 783 of the WHRN protein (p.Val783Glu). The valine residue is weakly conserved and there is a moderate physicochemical difference between valine and glutamic acid. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with WHRN-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at